Learn about the Effective Use, Analysis, and Best Practices for Collecting eCOA Data in Oncology Programs in a new educational webinar, 10 September. The webinar is hosted by PHT Corporation, the leading provider of technologies for collecting patient-driven eData for clinical research.
Patient-reported outcome (PRO) and electronic PRO (ePRO) measures are standard tools for directly eliciting the patient experience for clinical outcome assessments (COAs). Ever since regulators approved quality of life (QoL) data sufficient to prove efficacy, oncology trials have been leveraging COAs and eCOA for submissions.
PHT has been collecting patient- and clinician-reported data since 2000. The use of high quality patient-centered outcome data is an essential component for the informed decision-making of multiple stakeholders.
The webinar will be led by PHT Clinical Science & Consulting, with 100+ years of collective experience in ePROs and COAs, who will review
- Measures and instruments used to collect endpoint, symptom and QoL data, and special considerations for their translation and validation
- Oncology patient preference and compliance, based on literature and PHT experience
- Instruction on how to incorporate COAs and PROs into oncology clinical trial design
- FDA and CMPT minimum best practices to ensure data collection allows for examination of patients’ directly reported experiences
PHT Clinical Science & Consulting is led by Susan M. Dallabrida PhD who has over 21 years of experience as a senior scientist, consultant and director in clinical research and development, trial design and strategy, and product development. She is focused on instrument development and validation efforts for eCOA/ePRO, including the establishment of conceptual equivalence and psychometric validation of new instruments. Meet the team: http://bit.ly/consultingservicesteam
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enables clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.comfor more information on PHT. Follow PHT onLinkedIn, Facebook, Twitter, Google+ and YouTube.
